Legal Representation
Attorney
Jonathan C. Hill
USPTO Deadlines
Next Deadline
57 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 30, 2025
Extension Available
Until December 30, 2025
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 1, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 30, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 31, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 5, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 4, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 4, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 4, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 4, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 23, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 12, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 23, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Providing public policy information in the field of improving healthcare for rural and underserved populations; Providing public policy information in the field of overall community health; Providing public policy information in the field of improving the treatment and diagnosis of health conditions; Providing public policy information in the field of precision medicine; Providing public policy information in the field of clinical trial eligibility; Providing business information about clinical trial eligibility; Business services provided to organizers of clinical trials, namely, providing information about populations of potential clinical trial participants; Business services provided to organizers of clinical trials, namely, providing targeted notifications to individuals about potential eligibility for clinical trials
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RESEARCH"